Covered recipient · General Payments record
PABLO C TEVENI
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,485.35
- Reported across 99 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $511.89 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $124.99 | 1 |
| Acerta Pharma LLC | $116.08 | 1 |
| ABBVIE INC. | $63.60 | 1 |
| Lilly USA, LLC | $34.67 | 2 |
| Janssen Pharmaceuticals, Inc | $29.82 | 1 |
| Corium, Inc. | $29.00 | 1 |
| Averitas Pharma Inc. | $23.75 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $22.37 | 1 |
| PFIZER INC. | $20.39 | 1 |
| Astellas Pharma US Inc | $17.27 | 1 |
| Novo Nordisk AS | $16.85 | 1 |
| Paratek Pharmaceuticals, Inc. | $13.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $63.60 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106212690 | CMS |
| Amgen Inc. | $124.99 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116174662 | CMS |
| Astellas Pharma US Inc | $17.27 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139423467 | CMS |
| AstraZeneca Pharmaceuticals LP | $116.08 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105264558 | CMS |
| Averitas Pharma Inc. | $23.75 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133448926 | CMS |
| Corium, LLC | $29.00 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100199220 | CMS |
| Janssen Pharmaceuticals, Inc | $29.82 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078206693 | CMS |
| Lilly USA, LLC | $17.02 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135258372 | CMS |
| Lilly USA, LLC | $17.65 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135302616 | CMS |
| Novartis Pharmaceuticals Corporation | $22.37 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087437720 | CMS |
| Novo Nordisk Inc | $16.85 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096605295 | CMS |
| Paratek Pharmaceuticals, Inc. | $13.10 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113921444 | CMS |
| PFIZER INC. | $20.39 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131263411 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.